Speaker Profile
Ph.D., Director of the Neuroscience Translational Research Division, USC
Biography
Dr. Rissman is Professor Physiology and Neuroscience and the W.M. Keck Endowed Chair in Medicine at the University of Southern California (USC). He is the founding Director of the Neuroscience Translational Research Division (NTRD) at USC’s San Diego campus, Alzheimer’s Therapeutic Research Institute (ATRI). Concurrently with his research, Dr. Rissman also serves as the Biomarker Unit Lead for the Alzheimer’s Clinical Trials Consortium (ACTC) and USC’s Alzheimer’s Disease Research Center. Using biobanked human specimens, animal and cell models, the goal of Dr. Rissman’s basic science research is to identify and validate plasma biomarkers for Alzheimer’s Disease and Related Disorders (ADRD) to better understand mechanisms of neurodegeneration and to streamline clinical trials recruitment. Work from Dr. Rissman’s lab has led to the validation of plasma biomarkers that predict AD brain neuropathology and progression of dementia. Using animal and cell culture models, Dr. Rissman’s lab is focused on identifying synucleinopathy in AD can be identified.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Judy Faulkner, Epic
• Peter DeVault, Epic
RNA Therapeutics Beyond mRNA: siRNA, ASOs, and snRNA
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Stem Cell-Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Gudrun Stengel, Alida Biosciences
• Jarret Glasscock, Cofactor Genomics
• "Phil Febbo, Veracyte
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
